Novavax begins Portion 1 scientific trial of coronavirus vaccine candidate – Reuters

Novavax Inc said on Monday it has started the Portion 1 scientific trial of a novel coronavirus vaccine candidate and has enrolled the trial’s first contributors, with preliminary outcomes slated for July.


Reuters brings you the most up-to-date business, finance and breaking news video from across the globe. Our repute for accuracy and impartiality is unparalleled.

Get the most up-to-date news on:

Educate Reuters on Fb:

Educate Reuters on Twitter:

Educate Reuters on Instagram:

Read More

Leave a comment

Stay up to date
Register now to get updates on promotions and coupons.

Shopping cart